Skip to main content

Hypertension Outcomes and Implementation Science Research in Low, Middle-Income Countries

  1. The Malawi College of Medicine and its partners are building non-communicable diseases’ (NCDs’) research capacity through a grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Insti...

    Authors: Adamson S. Muula, Mina C. Hosseinipour, Martha Makwero, Johnstone Kumwenda, Prosper Lutala, Mary Mbeba, Sarah Rylance, Collins Mitambo and Moffat Nyirenda
    Citation: Trials 2021 22:65
  2. Vietnam has been experiencing an epidemiologic transition to that of a lower-middle income country with an increasing prevalence of non-communicable diseases. The key risk factors for cardiovascular disease (C...

    Authors: Duc A. Ha, Oanh T. Tran, Hoa L. Nguyen, Germán Chiriboga, Robert J. Goldberg, Van H. Phan, Cuc T. Nguyen, Giang H. Nguyen, Hien V. Pham, Thang T. Nguyen, Thanh T. Le and Jeroan J. Allison
    Citation: Trials 2020 21:985
  3. Hypertension and diabetes are among the most common and deadly chronic conditions globally. In India, most adults with these conditions remain undiagnosed, untreated, or poorly treated and uncontrolled. Innova...

    Authors: Shivani A. Patel, Hanspria Sharma, Sailesh Mohan, Mary Beth Weber, Devraj Jindal, Prashant Jarhyan, Priti Gupta, Rakshit Sharma, Mumtaj Ali, Mohammed K. Ali, K. M. Venkat Narayan, Dorairaj Prabhakaran, Yashdeep Gupta, Ambuj Roy and Nikhil Tandon
    Citation: BMC Health Services Research 2020 20:1022
  4. Physician shortage is a major barrier to hypertension (HTN) control in Ghana, with only one physician to 10,000 patients in 2015, thus limiting its capacity for HTN control at the primary care level such as th...

    Authors: Kwaku Poku Asante, Juliet Iwelunmor, Kingsley Apusiga, Joyce Gyamfi, Solomon Nyame, Kezia Gladys Amaning Adjei, Angela Aifah, Kwame Adjei, Deborah Onakomaiya, William F. Chaplin, Gbenga Ogedegbe and Jacob Plange-Rhule
    Citation: Trials 2020 21:825
  5. Hypertension is a major risk factor for cardiovascular disease (CVD). Despite advances in hypertension prevention and treatment, the proportion of patients who are aware, treated and controlled is low, particu...

    Authors: Alejandra Paniagua-Avila, Meredith P. Fort, Russell E. Glasgow, Pablo Gulayin, Diego Hernández-Galdamez, Kristyne Mansilla, Eduardo Palacios, Ana Lucia Peralta, Dina Roche, Adolfo Rubinstein, Jiang He, Manuel Ramirez-Zea and Vilma Irazola
    Citation: Trials 2020 21:509
  6. Hypertension is a major risk factor for cardiovascular disease (CVD), yet treatment and control rates for hypertension are very low in low- and middle-income countries (LMICs). Lack of effective referral netwo...

    Authors: Tim Mercer, Benson Njuguna, Gerald S. Bloomfield, Jonathan Dick, Eric Finkelstein, Jemima Kamano, Ann Mwangi, Violet Naanyu, Sonak D. Pastakia, Thomas W. Valente, Rajesh Vedanthan and Constantine Akwanalo
    Citation: Trials 2019 20:554